Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

Tekla Life Sciences Investors  as of 05/24/2017

NYSE / HQL Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  13.01%

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return 13.43% 18.24% 21.77% 24.17%
Lipper Pct. Rank 13 24 24 12
NAV Return 11.68% 16.46% 15.08% 14.15%
Lipper Pct. Rank 25 28 25 13
Premium/Discount History

10 YR Avg 5 YR Avg YTD Avg
-8.023% -2.136% -5.440%

NAV $20.30 Market Price $20.69
Net Change -$0.01 Market Change $0.05
Premium/Discount 1.92%
1 YR NAV Return 15.079%
1 YR NAV Rank 25
12-Mo Yield as of 4/30/2017 Yield Def
Income Only Yield 0.00%
Distribution Yield (Market) 7.71%
Most Recent Income Dividend $0.370
Ex-Div Date 4/21/2016
Most Recent Cap Gain Dividend $0.360
Ex-Div Date 2/24/2017
Dividend Frequency Quarterly
YTD Dividends --
YTD Capital Gains $0.360
Inception Date 5/8/1992
Fund Advisor Tekla Capital Management LLC
Manager & Tenure Team Managed
Phone 800-451-2597
Total Net Assets (mil) as of -- --
% Leveraged Assets as of 9/30/2016 --
Portfolio Turnover 31.00%
Mgmt Fees 1.036%
Expense Ratio 1.270%
Fund Objective
The Fund seeks long-term capital appreciation by investing primarily in equity and related securities of U.S. and foreign companies principally engaged in the development, production or distribution of products or services related to scientific advances in health care, agriculture and environmental management.
Top Holdings (as of 9/30/2016)
Gilead Sciences Inc ORD 8.45%
Celgene Corp ORD 6.95%
Biogen Inc ORD 6.00%
Incyte Corp ORD 5.91%
Regeneron Pharmaceuticals Inc ORD 4.32%
Vertex Pharmaceuticals Inc ORD 4.02%
Alexion Pharmaceuticals Inc ORD 3.77%
Biomarin Pharmaceutical Inc ORD 3.44%
Illumina Inc ORD 3.21%
Cepheid ORD 2.22%
Top Sectors (as of 9/30/2016)
Health Care 85.90%
Non Classified Equity 6.78%


Aberdeen Closed-End TV

Asset TV - CEF Channel

CEF Connect



Seeking Alpha CEF Articles
SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

© Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.